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present, both open and arthroscopic surgical treatment methods to
correct these deformities are advancing rapidly. Current state of the
art surgical treatment methods will be discussed as well as available
evidence demonstrating efﬁcacy of these treatment methods in relieving
symptoms as well as possibly affecting natural history of osteoarthritis
progression.
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OSTEOARTHRITIS YEAR IN REVIEW: REHABILITATION AND
OUTCOMES
A. Davis. Hlth.Care and Outcomes Res., Toronto Western Res. Inst., Toronto,
ON, Canada
Purpose: This review highlights seminal publications of rehabilitation
and outcomes in osteoarthritis of the hip or knee from the past year.
Methods:Medline, CINAHL, and Embase databases from September 2010
through June 2011 were searched using the key words ‘osteoarthritis’,
hip or knee, rehabilitation, physical therapy, exercise, and outcome(s),
limited to human and English. Studies of surgical interventions
were excluded unless they included evaluation of a rehabilitation
intervention. Rehabilitation intervention studies were included if they
were randomized trials or systematic reviews/meta-analyses and studies
related to outcomes were included if they contributed methodologically
to advancing outcome measurement. A total of 10 publications were
reviewed that thematically relate to interventions evaluating manual
therapy in hip or knee OA, tele-rehabilitation and performance measures
and participation as outcomes.
Results: Interventions: One systematic review of hip and knee OA, one
meta-analysis of knee OA and one additional small study of hip OA
provide limited support for the beneﬁt of manual therapy with exercise
for improving pain in the short term (three months). However, study
quality is low due to lack of blinding and disclosure of co-intervention.
One RCT in knee replacement of usual outpatient physiotherapy versus
internet-based tele-rehabilitation based on a non-inferiority analysis
demonstrated comparable outcomes on pain and performance measures.
The tele-rehabilitation group had improved outcomes in WOMAC
function and stiffness.
Outcomes: Three studies demonstrated that observed performance
measures such as timed walk tests and stair-climbing and timed-up-
and-go measure concepts different from self-report of difﬁculty with
physical function. Additionally, one study showed differential times of
recovery following TKR.
Two studies evaluated participation. One demonstrated the conceptual
distinction of activity limitations and participation and a second re-
analyzed trial data from knee OA and back pain studies demonstrating
larger effects in participation for arthroscopic lavage and physiotherapy
interventions than for activity.
Conclusions: Interventions of manual therapy for hip and knee OA
provided limited evidence of effectiveness. These studies are of limited
quality due to lack of blinding and disclosure of co-intervention. Tele-
rehabilitation may be a viable option to improve access to rehabilitation
post joint replacement for those in rural and remote areas.
Data continue to support the need to include performance measures
as well as patient-reported outcomes in evaluating outcomes in OA.
Additionally, measures of participation need to be included as core
outcomes.
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OSTEOARTHRITIS YEAR IN REVIEW: BIOMARKERS
Y. Henrotin. Univ. of Liege, Liege, Belgium
Purpose: This lecture is a summary of the published studies, ongoing
researches, initiatives and consensus building during last 12 months in
the ﬁeld of biochemical markers.
Methods: To select OA biomarker studies for this year in review, I
performed a systematic search in the pubmed database limited to the
prior 12 months using the query terms OA and biomarkers and reviewed
the abstracts of the 2011 OARSI World congress.
Results: This year was dominated by the publication of the OARSI/FDA
white paper on the “Application of biomarkers in the development of
drug intended for the treatment of osteoarthritis”. This white paper
contains responses to queries posed by the FDA in an effort to consider
revision of guidelines for drug development, recommendations on
biomarkers qualiﬁcation, a summary of the critical needs in the OA
biomarker ﬁeld and an agenda of research to advance the science
of OA-related biomarkers. Another signiﬁcant occurrence of this year
was the identiﬁcation by proteomic technics of a great number of new
potential biomarkers. Among these new biochemical markers, there are
ﬁbulin-3 fragments (Fib3–1 and Fib3–2), V65 vitronectin fragment, C3f
peptide, Cartilage Acidic protein-1 or cathepsin generated fragments
of C-reactive protein. Finally, D-COMP, a unique deaminated cartilage
oligomeric matrix protein (COMP), was the ﬁrst biomarker to show
speciﬁcity for hip osteoarthritis.
Conclusions: The last 12 months were marked by the emergence of a
large number a new biomarkers which need to be qualiﬁed in large
cohortes in the respect of the recommendations published by the
OARSI/FDA working group.
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OSTEOARTHRITIS YEAR IN REVIEW 2011: IMAGING
A. Guermazi. Boston Univ. Sch. of Med., Boston, MA, USA
Application of imaging is increasingly playing an important role in
osteoarthritis (OA) research. Currently, radiography, MRI and ultrasound
are commonly used as an imaging tool. MRI assessment of OA features
can be morphologic or functional. Morphologic assessment includes
semiquantitative and quantitative analysis and research efforts are
actively ongoing using both methods. Several scoring systems already
exist, but new semiquantitative scoring methods for knee and hip
OA using MRI were developed in addition. The OARSI OA imaging
working group published a series of key reports this year, reviewing the
importance of radiography and MRI as a research tool. Although recent
research efforts have discovered that radiography is relatively insensitive
for detection of OA pathology compared to MRI, we had no choice but
to use the radiographic deﬁnition of OA in clinical trials because of a
lack of MRI deﬁnition of OA and FDA-approved endpoints based on MRI
ﬁndings. In an attempt to alleviate this problem, a Delphi exercise was
performed to develop a testable MRI deﬁnition of structural OA and
its results were published. This presentation reviews the publications
related to imaging of OA, published in English between December 2010
and September 2011, excluding preclinical or in vitro data. This is not a
systematic review and the selection of papers included is based on the
expert opinions of the presenter, from a musculoskeletal radiologist’s
perspective.
